Background: This study examined the pathophysiological abnormalities in Arab Americans with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). Subjects and Methods: Homeostasis model assessment of insulin resistance (HOMA-IR), homeostasis model assessment of insulin secretion (HOMA-%b), and the Matsuda Insulin Sensitivity Index composite (ISI composite ) were calculated from the fasting and stimulated glucose and insulin concentrations measured during the oral glucose tolerance test in a populationbased, representative, cross-sectional sample of randomly selected Arab Americans. Results: In total, 497 individuals (42 -14 years old; 40% males; body mass index [BMI], 29 -6 kg/m
Introduction
I mpaired fasting glucose (IFG) and impaired glucose tolerance (IGT) have been identified as independent precursors for the development of type 2 diabetes. [1] [2] [3] Studies have illustrated that different pathophysiological abnormalities characterize isolated IFG and isolated IGT. Individuals with isolated IFG have decreased hepatic insulin sensitivity accompanied by reduction in basal and first-phase insulin secretion. [3] [4] [5] [6] Those with isolated IGT have minimal reduction in hepatic insulin sensitivity but instead have predominant reduction in peripheral insulin sensitivity and reduced firstand second-phase insulin secretion. [3] [4] [5] 7, 8 In patients with combined IFG/IGT, decreased hepatic/peripheral insulin sensitivity and profound reduction in insulin secretion have been documented. 3, 4, 6 Emerging evidence also suggests that ethnic variation in the natural history, etiology, and underlying pathology of IFG and IGT exists. 4, [8] [9] [10] Abdul-Ghani et al. 10 demonstrated differences in the degree of insulin secretion and insulin sensitivity among different ethnic populations with isolated IGT; specifically, Arabs had a significantly greater reduction in insulin secretion and lower reduction in insulin sensitivity compared with Japanese and Mexican Americans. Decreased insulin sensitivity was the predominant contributory factor to the decline in b-cell function in Mexican Americans, whereas the decline in both insulin sensitivity and secretion influenced conversion from normal glucose tolerance (NGT) to IGT in Japanese subjects. 10 In another study, a more significant impairment in b-cell compensation for the degree of insulin sensitivity was observed in Arab women with gestational diabetes compared with Scandinavian women after adjustment for body mass index (BMI). 11 We have demonstrated that the prevalence of diabetes and prediabetes is disproportionately high among Arab Americans, posing a major public health burden. 12 Greater insight into the pathophysiological abnormalities leading to diabetes in this population will facilitate the identification of pharmacological strategies that may be used as early interventions to prevent or delay the disease progression. 13 Insulin sensitivity and b-cell function have been examined in a small number of Arabs with isolated IGT, 10 but to date no studies have described the transition in glucose homeostasis from NGT to IFG, IGT, or combined IFG/IGT in this population. In this analysis, we aim to compare the pathophysiological defects of isolated IFG, isolated IGT, combined IFG/IGT, and diabetes relative to NGT in a representative, cross-sectional sample of Arab Americans. Preliminary results have been presented elsewhere in abstract form. 14 
Subjects and Methods
The methods of this cross-sectional, population-based study have been described in detail elsewhere. 12 In brief, an initial sampling frame of households was constructed in two geographical areas of Dearborn, MI, that are predominantly inhabited by Arab Americans. Nonpregnant adults 20-75 years of age with native Arab ancestry were randomly selected from these sampling frames. Arab Americans were defined by self-report of Arab ancestry of the individual, a parent, or a grandparent. The study was approved by the Wayne State University Institutional Review Board. All participants provided written informed consent.
Eligible individuals reported to the clinic following a 12-h overnight fast. Standardized questionnaires translated into Arabic were used to assess demographic factors. Height and body weight were measured in light clothing and without shoes. BMI was calculated as the body weight (in kilograms) divided by the square of the height (in meters).
Fasting blood samples were collected for measurement of plasma glucose and serum insulin and lipid concentrations. Individuals without documented diabetes underwent a 75-g oral glucose tolerance test (OGTT), and blood samples were collected at 120 min for measurement of plasma glucose and serum insulin levels. Plasma glucose concentrations were measured by an automated glucose oxidase method using Behring Diagnostics (La Jolla, CA) reagents (SVR glucose test). The serum insulin level was measured with a double antibody radioimmunoassay (Linco Research, St. Charles, MO) and was standardized against the International Reference Preparation (National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom). Total cholesterol and triglyceride concentrations were measured using enzymatic colorimetric techniques (Cobas Mira Chemstation; Roche, Indianapolis, IN). Highdensity lipoprotein cholesterol was measured with a highdensity lipoprotein direct assay using the elimination approach and meeting the National Cholesterol Education Program guidelines for precision and accuracy (Cobas Mira Chemstation). Low-density lipoprotein cholesterol was calculated using the equation of Friedewald et al. 15 Individuals were considered to have diabetes if they reported a previous medical diagnosis of diabetes and/or were using insulin or oral antihyperglycemic agents. Glucose tolerance status of individuals without a previous diagnosis of diabetes was defined according to the 2012 American Diabetes Association OGTT-based diagnostic criteria. 16 Insulin resistance was estimated using the homeostasis model assessment (HOMA) of insulin resistance (HOMA-IR) and was defined as (fasting serum insulin [in lU/mL] · fasting plasma glucose [in mmol/L])/22.5. 17 Insulin secretion was calculated using the homeostasis model assessment of bcell function (HOMA-%b) and was calculated as (fasting se-
Insulin sensitivity was also measured using the Matsuda Insulin Sensitivity Index composite (ISI composite ), calculated as
, where k ( = 10,000) is the constant, G 0 and G 120 are the plasma glucose concentrations at times 0 and 120 min, respectively, and I 0 and I 120 are the plasma insulin concentrations at times 0 and 120 min, respectively. 18 Descriptive statistics were performed to compare the demographic characteristics of participants by glucose tolerance status. Data are expressed as mean -SD values or percentages. Depending on whether the outcome measure was continuous or categorical, data were analyzed using analysis of variance or v 2 test, respectively. Multivariate linear regression models for HOMA-IR, HOMA-%b, and ISI composite were built with backward selection with a removal threshold of P = 0.2 with linear age, linear BMI, and sex considered as covariates. Analyses were completed using the statistical software package STATA version 11.0 (StataCorp, College Station, TX). A two-tailed P < 0.05 was considered statistically significant.
Results
In total, 542 Arab Americans participated in this study. Of these, 45 individuals without a history of diabetes did not have complete OGTT data and were excluded from this analysis, for a final study sample of 497. Demographic characteristics are presented in Table 1 . Males accounted for 40% of the study population. The mean age was 42 -14 years. The mean BMI was 29 -6 kg/m 2 . Isolated IFG, isolated IGT, combined IFG/IGT, and diabetes were present in 27%, 4%, 9%, and 21% of the participants, respectively.
Mean -SD age was significantly higher in individuals with isolated IFG (39 -12 years), isolated IGT (45 -14 years), and those with combined IFG/IGT (46 -16 years) compared with those with NGT (37 -12 years). Compared with NGT, there was a significantly higher percentage of men with isolated IFG (P < 0.001) but a smaller percentage with isolated IGT (P = 0.03) and combined IFG/IGT (P = 0.007). concentrations were significantly lower in those with isolated IFG, isolated IGT, and combined IFG/IGT compared with those with NGT (all comparisons P < 0.05). Fasting insulin concentrations were significantly higher in individuals with isolated IFG (P < 0.001) and those with combined IFG/IGT (P < 0.001) but not in those with isolated IGT (P = 0.61) relative to NGT. Individuals with isolated IFG, isolated IGT, and combined IFG/IGT had significantly higher postprandial insulin concentrations compared with those with NGT (all comparisons P < 0.001).
As shown in Table 1 , there were few differences in demographic characteristics between those with isolated IFG, isolated IGT, and combined IFG/IGT. Individuals with isolated IGT were older and had higher postprandial insulin concentrations but significantly lower fasting insulin concentrations relative to those with isolated IFG. Age, total cholesterol, and fasting and postprandial insulin concentrations were higher in individuals with combined IFG/IGT compared with those with isolated IFG. Individuals with combined IFG/IGT also had significantly higher fasting insulin concentrations relative to those with isolated IGT.
Measures of HOMA-IR, HOMA-%b, and ISI composite are presented in Table 2 . Compared with individuals with NGT (2.9 -1.6), the mean ( -SD) HOMA-IR progressively increased in individuals with isolated IFG (4.8 -2.7, P < 0.001), combined IFG/IGT (6.0 -4.3, P < 0.001), and diabetes (9.7 -8.3, P < 0.001) but not in those with isolated IGT (3.0 -1.7, P = 0.87). After adjustment for sex, and BMI, these associations remained unchanged. Additionally, HOMA-IR was significantly higher in individuals with isolated IFG compared with those with isolated IGT (P = 0.002) and with combined IFG/ IGT versus both isolated IFG (P = 0.025) and isolated IGT (P = 0.003).
Whole-body insulin sensitivity measured with the ISI composite was significantly lower in individuals with isolated IFG (3.9 -2.3, P < 0.001), isolated IGT (2.8 -1.5, P < 0.001), combined IFG/IGT (1.9 -1.1, P < 0.001), and diabetes (1.6 -1.1, P < 0.001) relative to those with NGT (6.1 -3.5). After adjustment for sex, and BMI, these associations remained unchanged. Furthermore, insulin sensitivity was significantly lower with isolated IGT relative to isolated IFG (P = 0.010) and with combined IFG/IGT versus both isolated IFG (P < 0.001) and isolated IGT (P = 0.013).
Compared with NGT (161.3 -92.0), HOMA-%b was significantly decreased with the onset of diabetes (113.7 -124.9, P < 0.001). After adjustment for age, sex, and BMI, IFG was also significantly associated with a decline in HOMA-%b relative to NGT (P = 0.005). HOMA-%b was significantly lower in individuals with isolated IFG compared with those with isolated IGT (P = 0.021) and combined IFG/IGT (P = 0.029). There were no differences noted between combined IFG/IGT versus isolated IGT (P = 0.63).
Discussion
This study was conducted to examine potential differences in the pathophysiologic mechanisms of insulin resistance or sensitivity and insulin secretion across the spectrum of glucose intolerance in a population-based random sample of Arab Americans. Insulin sensitivity as measured by the adjusted HOMA-IR was significantly lower with isolated IFG versus isolated IGT and in combined IFG/IGT versus isolated 53 (28) 69 (51) 11 (50) 21 (49) 45 ( BMI, body mass index; DM, diabetes mellitus; HDL, high-density lipoprotein; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LDL, low-density lipoprotein; NGT, normal glucose tolerance.
IFG and isolated IGT. On the other hand, insulin sensitivity as measured by the adjusted ISI composite was significantly lower with isolated IGT versus isolated IFG and in combined IFG/ IGT versus isolated IFG and isolated IGT. Adjusted HOMA%b was significantly lower with isolated IFG versus isolated IGT and combined IFG/IGT. Our findings are consistent with several but not all studies that used the HOMA method for estimation of insulin resistance. Several studies have suggested that differences in HOMA-IR between the glucose intolerance states exist; insulin sensitivity is significantly decreased in individuals with isolated IFG and combined IFG/IGT. 3, 4, [19] [20] [21] Isolated IGT using HOMA-IR was also associated with a significant decline in insulin sensitivity in some but not all studies. [3] [4] [5] [19] [20] [21] [22] In addition to HOMA measurements, the insulin sensitivity index has been widely used to describe the pathophysiologic mechanisms of glucose intolerance. The ISI composite , which estimates whole-body insulin sensitivity using two sample points for plasma glucose and insulin measurements, has been shown to be comparable to insulin sensitivity measures using five sample points. 18 A study of 1,264 Asian Indians has reported significant differences in NGT versus both isolated IFG and isolated IGT as calculated using HOMA-IR and significant differences in NGT versus isolated IFG, isolated IGT, combined IFG/IGT, and diabetes as calculated using the modified Matsuda index. 23 Using the Matsuda ISI composite in our population, we have demonstrated significant differences in all categories of glucose intolerance compared with NGT and when comparing isolated IFG versus isolated IGT and combined IFG/IGT versus isolated IFG and isolated IGT. Several studies have described a significant decline in b-cell function in individuals with isolated IFG, isolated IGT, and combined IFG/IGT. 3, 4, 19, 20, 22 Studies assessing insulin secretion using HOMA-%b resulted in findings similar to those reported in this study with respect to comparisons among isolated IFG, isolated IGT, and combined IFG/IGT. 5, 20, 22 There are several potential limitations to our study. First, we used the HOMA method for estimating insulin resistance and secretion in this population-based randomly selected sample of Arab Americans. Although this method has been correlated to the hyperinsulinemic-euglycemic clamp, fasting glucose levels significantly influence the accuracy of HOMA estimation indices. 4, 24 In addition, the indices in the formula do not account for potential variations in insulin clearance. Second, postprandial insulin concentrations were derived from a single OGTT testing, limiting our ability to assess the hyperbolic relation between insulin secretion to insulin sensitivity in individuals with isolated IFG, isolated IGT, and combined IFG/IGT. 25 Third, IFG was the most prevalent abnormality followed by diabetes in our population. Using the current American Diabetes Association criteria, the prevalence of IFG of 27% shown here is 19% higher than the rate we previously reported, stemming from a disproportionately high number of individuals with isolated IFG compared with those with isolated IGT or combined IFG/IGT. 12, 16 It is plausible that the lack of significant changes in HOMA-%b shown here in individuals with isolated IGT or combined IFG/IGT may in part be due to the small sample size of these groups. Fourth, there are multiple factors that can influence insulin resistance such as waist-hip ratio, hypertension, hypertriglyceridemia, low high-density lipoprotein cholesterol, C-peptide, hemoglobin A1C, and fasting insulinemia that could not be systematically 1022 SALINITRI ET AL.
assessed. Finally, the cross-sectional design of our study limited the ability to assess the natural progression of these metabolic abnormalities across the disease continuum.
In conclusion, given the high prevalence of prediabetes and diabetes in the Arab American population, a clear understanding of the underlying pathophysiological mechanisms of the glucose intolerance states leading to diabetes is important. This study suggests that differences in the metabolic defects in Arab Americans with IFG and/or IGT may exist and may require different strategies for the prevention of diabetes. It appears that interventions that encompass enhancing insulin sensitivity and preserving b-cell function may be more efficacious for preventing diabetes in this vulnerable population.
